Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | QPCT | Q16769 | 6/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL406663 | 0.84 | TBXAS1 (0.59) | TBXAS1MEN1KMT2AATMQPCT | |
| Hydrochloric Acid SCHEMBL27901082 | 0.82 | TBXAS1 (0.57) | TBXAS1MEN1KMT2AATMQPCT | |
| SCHEMBL12802207 | 0.80 | TBXAS1 (0.52) | TBXAS1MEN1KMT2AATMQPCT | |
| SCHEMBL16638800 | 0.80 | TBXAS1 (0.46) | TBXAS1MEN1KMT2AATMQPCT | |
| SCHEMBL21408577 | 0.78 | TBXAS1 (0.58) | TBXAS1TSHRKDM4ETP53ALDH1A1 | |
| SCHEMBL21408418 | 0.78 | TBXAS1 (0.58) | TBXAS1TSHRKDM4ETP53ALDH1A1 | |
| SCHEMBL21141580 | 0.78 | TBXAS1 (0.55) | TBXAS1MEN1KMT2AATMQPCT | |
| SCHEMBL4354536 | 0.77 | KMT2A (0.55) | TBXAS1MEN1KMT2AATMQPCT | |
| SCHEMBL23071645 | 0.76 | TBXAS1 (0.49) | TBXAS1MEN1KMT2AATMQPCT | |
| SCHEMBL22472280 | 0.76 | QPCT (0.51) | TBXAS1MEN1KMT2AATMQPCT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2860183-A9 | REACTIVE IONIC LIQUID AND ION-IMMOBILIZED METAL OXIDE PARTICLES PRODUCED USING SAME, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER | Sumitomo Riko Company Limited (JP) | 2015-05-27 | — | — | EP | disclosed |
| US-20150137666-A1 | REACTIVE IONIC LIQUID, AND ION-IMMOBILIZED METAL OXIDE PARTICLE, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER USING SAME | SUMITOMO RIKO COMPANY LIMITED (JP) | 2015-05-21 | — | — | US | disclosed |
| EP-2860183-A1 | REACTIVE IONIC LIQUID AND ION-IMMOBILIZED METAL OXIDE PARTICLES PRODUCED USING SAME, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER | Sumitomo Riko Company Limited (JP) | 2015-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150137666-A1 | REACTIVE IONIC LIQUID, AND ION-IMMOBILIZED METAL OXIDE PARTICLE, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER USING SAME | L1CAM, ITGA2B, AS3MT | TBXAS1 4139/4885MEN1 2216/4885KMT2A 700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.